Technologies
PDF


WARF: P05092US

H3 Equine Influenza A Virus


INVENTORS -

Christopher Olsen, Gabriele Landolt, Alexander Karasin

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in an isolated H3 equine influenza A virus that could be used for vaccine development.
OVERVIEWInfluenza is a major respiratory disorder that affects humans and many animals, including horses. New strains of influenza arise frequently, creating a continuous need to isolate new influenza viruses for vaccine production.
THE INVENTIONUW-Madison researchers have developed an isolated H3 equine influenza A virus, as well as methods of preparing and using the virus. This virus, which was isolated following a May 2003 outbreak of respiratory disease in horses, represents a new line of equine influenza virus. It is genetically related to a virus that caused an outbreak of influenza among horses in South Africa and to a virus isolated from greyhound dogs in Florida. This virus will be useful as part of an up-to-date vaccine against equine influenza.
APPLICATIONS
  • Equine influenza vaccines
KEY BENEFITS
  • Provides a potential new influenza strain for equine and possibly canine vaccine development
Contact Information
For current licensing status, please contact Emily Bauer at emily@warf.org or 608-960-9842.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.